How a Tyrosine Kinase Inhibitor Is Giving Hope to Lung Cancer Patients
Tuesday, 20 August 2019
According to the American Cancer Society, lung cancer is the leading cause of cancer death each year and accounts for approximately 13% of all new cases. The most common type being non-small cell lung cancer (NSCLC). Although smoking is the biggest contributor, other factors such as genetics and environmental pollutants contribute to lung cancer of
- Published in Emerging Targets
No Comments